【爱尔康（中国）眼科产品有限公司】爱尔康 爱尔康公司为全球最大的眼科保健公司，拥有65余年的光辉历史， 现为诺华集团第二大业务部门，2010年实际综合销售约为94亿美元。爱尔康公司拥有员工22,000余名，总部设在美国德克萨斯州的沃斯堡。爱尔康公司在三条业务线 - 手术产品、药品及视力保健产品上提供了无与伦比的眼科保健产品宽度，满足眼科专家及患者的各种需求。爱尔康公司在75个国家拥有分公司，在全球180个国家内销售产品。如需获取更多信息，请浏览: www.alcon.com 爱尔康中国 爱尔康于1995年作为法人实体进入中国。今天，爱尔康中国在全国范围内拥有700余名员工服务于我们的眼科保健专家。我们的企业目标是在手术产品、药品及视力保健领域成为患者的首选。爱尔康中国一贯秉承其对中国眼科医生及患者的承诺，不断加强相互间的合作，携手共创辉煌的明天。爱尔康中国最宝贵的资产是我们的员工。围绕“团结一心，共创辉煌”的企业文化，我们齐心协力来实现公司的目标及员工的个人目标。同时，我们也在逐年的通过扩大人员规模，增加我们的资源，为我们的员工提供培训及强有力的支持来对中国的眼科业务进行投资，这将使我们能够在中国市场占据领导地位，成为中国乃至全球眼科保健公司中的翘楚。 ALCON Building on its heritage of more than 65 years, Alcon, the global leader in eye care, is the second largest division of the Novartis Group with combined pro-forma sales of approximately USD 9.4 billion in 2010. Alcon has more than 22,000 employees with headquarters in Fort Worth, Texas, U.S.A. Alcon’s three businesses - Surgical, Pharmaceutical and Vision Care - meet the diverse needs of eye care professionals and patients offering the widest spectrum of eye care products with operations in 75 countries and products available in 180 markets. For more information, visit www.alcon.com. Alcon China Alcon entered into China as a legal entity in 1995. Alcon China has more than 700 employees today within all provinces in China serving eye care professionals. Our organizational objective at Alcon China is to be the first choice in eye care for patients needing therapy within the surgical, pharmaceutical, and vision care areas.Alcon China continues to keep its commitment to all eye care professionals and patients in China to enhance our cooperation together and ensure a bright future. We will continue to work closely with all Ophthalmologists and other eye care staff in China as a partner and consultant to ensure the best possible outcomes for all patients. Alcon China’s best asset is our people, we have built a company culture centered around “One Team, One Family, One Alcon China”, where we all work together to achieve the companies goals as well as every employees own personal goals. At the same time we will invest year to year in the business of Ophthalmology in China thru the addition of more people, increasing our resources, training, and strong support for all our employees which will allow us to be in a leadership role within China market and continue as the number one eye care company globally as well as in China.